Fortrea Holdings Inc. FTRE Accounts Receivable, Credit Loss Expense (Reversal)

Accounts Receivable, Credit Loss Expense (Reversal) at other companies

Charles River LaboratoriesCRL

——

Revenue$636.5M-2.3%

Gross profit$123.6M+6.1%

Operating income-$3.4M+99.3%

Net income-$23.6M+95.8%

EPS (diluted)-$0.25+96.0%

Cash & equivalents$147.5M+45.2%

Total debt$1.1B-13.1%

Total equity$525.9M-38.8%

Total assets$2.7B-14.0%

Operating cash flow-$17.0M+86.3%

CapEx$8.0M+176%

Free cash flow-$25.0M+80.3%

Market cap$1.61B+29.3%

Enterprise value$2.58B-0.8%

P/S0.6×+0.1×

Gross margin18.9%-1.3pp

Operating margin-13.1%-4.1pp

Net margin-16.5%-5.0pp

FCF margin5.8%+1.7pp

Return on equity-64.5%0.0pp

Debt / equity2.1×+0.6×

Current ratio0.9×0.0×

Reported directly by Fortrea Holdings Inc. in its filing.

Tagged under the XBRL concept us-gaap:ProvisionForDoubtfulAccounts.

The official record: Fortrea Holdings Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Connect your AI assistant and compare it to peers, right in your chat.

What is Fortrea Holdings Inc.'s accounts receivable, credit loss expense (reversal)?: Fortrea Holdings Inc. (FTRE) reported accounts receivable, credit loss expense (reversal) of $3M in Q1 2026.
How has Fortrea Holdings Inc.'s accounts receivable, credit loss expense (reversal) changed year-over-year?: Fortrea Holdings Inc.'s accounts receivable, credit loss expense (reversal) decreased by 33.3% year-over-year, from $4.5M to $3M.